Skip to content

Geron GERN Earnings yield

Earnings yield at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
5.9%+1.6pp
Incyte logo
IncyteINCY
7.6%+7.5pp
Immunome logo
ImmunomeIMNM
-9.1%-3.9pp
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
-11.8%-4.5pp
Arcus Biosciences logo
Arcus BiosciencesRCUS
-13.6%-5.7pp
Celcuity logo
CelcuityCELC
-3.5%-1.7pp

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$888.51M-8.6%
Enterprise value$973.78M-6.2%
P/S4.7×-174×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Calculated from Geron’s reported figures.

Based on trailing twelve months.

The official record: Geron’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's earnings yield?
Geron (GERN) reported earnings yield of -7.1% in Q1 2026.
How has Geron's earnings yield changed year-over-year?
Geron's earnings yield increased by 48.6% year-over-year, from -13.7% to -7.1%.
What is the long-term trend for Geron's earnings yield?
Over 5 years (2020 to 2025), Geron's earnings yield has grown at a -7.7% compound annual growth rate (CAGR), from -14.8% to -9.9%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.